Stay updated with breaking news from மசிமோ வேர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
May 11, 2021 healthcaretechnology Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesia & Clinical Research in which Dr. Debdipta Das and colleagues at Medical College Kolkata in India evaluated the utility of Masimo O3® Regional Oximetry to aid in monitoring septic shock patients admitted to the ICU.1 O3, available on the Masimo Root® Patient Monitoring and Connectivity Platform, uses noninvasive near-infrared spectroscopy (NIRS) to enable monitoring of regional oxygen saturation (rSO2) in the region of interest, such as the brain or cerebral tissue (CrSO2). The researchers found that O3 trends correlated significantly with a variety of other hemodynamic variables and lactic acid levels commonly used in the monitoring of septic shock patients. They also found rSO2 values differed sign ....
(Photo by John Fedele/ Getty Images) The interoperability and connectivity of medical devices are widely recognised as important factors in helping hospitals achieve better patient data flow, synchronisation and harmonisation. “Hospitals need to connect devices that are not natively connected and maximise interoperability across the continuum of care so all patient data can be accurately and efficiently captured and presented to clinicians in the most suitable ways,” explains Joe Kiani, CEO and founder of medtech firm Masimo. The global company provides technologies and solutions to help hospitals and healthcare systems improve their patient outcomes and reduce the cost of care. ....
Article content Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 NEUCHATEL, Switzerland â Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARDS). 1 To gauge the impact, the researchers used the Masimo Root ® Patient Monitoring and Connectivity Platform with O3 ® Regional Oximetry, which uses near-infrared spectroscopy (NIRS) to enable monitoring of tissue oxygen saturation (rSO ....
Press release content from Business Wire. The AP news staff was not involved in its creation. Masimo Monitoring Solutions Promote Newborn and Maternal Safety March 8, 2021 GMT Masimo Newborn Sensor (Photo: Masimo) NEUCHATEL, Switzerland (BUSINESS WIRE) Mar 8, 2021 Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET ® pulse oximetry’s ability to measure during motion and low perfusion has helped newborns, neonates, and pediatric patients like no other pulse oximetry. Not only has Masimo SET ® helped clinicians reduce retinopathy of prematurity (ROP) 1 and improve screening for critical congenital heart disease (CCHD), 2-10 but it has helped push the standard of care for babies to new heights the evidence from CCHD studies with SET ®, for example, has been used in the establishment of screening guidelines used around t ....
Masimo Monitoring Solutions Promote Newborn and Maternal Safety yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.